Package Leaflet: Information for the User
Ixia 10 mg Film-Coated Tablets
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the Package Leaflet
Ixia belongs to a group of medicines called angiotensin II receptor antagonists. It lowers blood pressure by relaxing blood vessels.
Ixia is used to treat high blood pressure (also known as hypertension) in adults and children and adolescents from 6 to less than 18 years of age. High blood pressure can damage blood vessels in organs such as the heart, kidneys, brain, and eyes. In some cases, this can lead to a heart attack, heart or kidney failure, stroke, or blindness. Usually, high blood pressure does not present symptoms. It is important to control your blood pressure to avoid damage.
High blood pressure can be controlled with medicines such as Ixia tablets. Your doctor will probably also recommend that you make some lifestyle changes to help lower your blood pressure (for example, losing weight, stopping smoking, reducing the amount of alcohol you drink, and reducing the amount of salt in your diet). Your doctor may also recommend that you exercise regularly, such as walking or swimming. It is important to follow this advice from your doctor.
Do not take Ixia
Warnings and precautions
Tell your doctor before you start taking Ixia.
Tell your doctorif you are taking any of the following medicines used to treat high blood pressure (hypertension):
Your doctor may check your kidney function, blood pressure, and blood electrolyte levels (such as potassium) at regular intervals.
See also the information under the heading “Do not take Ixia”.
Tell your doctorif you have any of the following health problems:
Contact your doctor if you have severe, persistent diarrhea that causes significant weight loss. Your doctor will assess your symptoms and decide how to proceed with your blood pressure treatment.
Consult your doctor if you experience abdominal pain, nausea, vomiting, or diarrhea after taking Ixia. Your doctor will decide whether to continue treatment. Do not stop taking Ixia on your own.
As with any other medicine that lowers blood pressure, excessive lowering of blood pressure in patients with impaired blood flow to the heart or brain may cause a heart attack or stroke. Therefore, your doctor will carefully monitor your blood pressure.
You must inform your doctor if you are pregnant or think you might be. Ixia is not recommended at the start of pregnancy, and it must not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if taken at this stage (see section Pregnancy).
Black patients
As with other similar medicines, the blood pressure-lowering effect of Ixia is slightly less in black patients.
Elderly patients
If you are 65 years or older and your doctor decides to increase the dose of olmesartan medoxomil to 40 mg per day, you need your doctor to regularly check your blood pressure to ensure it does not decrease too much.
Children and adolescents
Ixia has been studied in children and adolescents. For more information, consult your doctor. Ixia is not recommended in children under 6 years of age, and it must not be used in children under 1 year of age, as there is no experience with it.
Using Ixia with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
In particular, inform your doctor or pharmacist about any of the following medicines:
Your doctor may need to change your dose and/or take other precautions:
If you are taking an angiotensin-converting enzyme inhibitor (ACE inhibitor) or aliskiren (see also the information under the headings “Do not take Ixia” and “Warnings and precautions”).
Taking Ixia with food and drinks
Ixia can be taken with or without food.
Pregnancy
You must inform your doctor if you are pregnant or think you might be. Your doctor will advise you to stop taking Ixia before you become pregnant or as soon as you know you are pregnant, and will advise you to take another medicine instead of Ixia. Ixia is not recommended at the start of pregnancy, and it must not be taken when you are more than 3 months pregnant, as it may cause serious harm to your baby if used from the third month of pregnancy.
Breast-feeding
Tell your doctor if you are breast-feeding or about to start breast-feeding. Ixia is not recommended for mothers who are breast-feeding, and your doctor may choose another treatment if you want to breast-feed, especially if your baby is newborn or premature.
If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
You may feel drowsy or dizzy during treatment for high blood pressure. If this happens, do not drive or use machines until the symptoms have gone away. Consult your doctor.
Ixia contains lactose
This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
Follow exactly the instructions of your doctor or pharmacist for taking this medicine. If you are not sure, ask your doctor or pharmacist again.
The recommended initial dose is 1 Ixia 10 mg tablet per day. If your blood pressure is not adequately controlled, your doctor may increase the dose to 20 mg or 40 mg per day or prescribe additional treatment.
In patients with mild to moderate kidney impairment, the maximum dose is 20 mg once daily.
Tablets can be taken with or without food. Take the tablets with a sufficient amount of water (for example, a glass). If possible, take your dose at the same time each day, for example, at breakfast time.
Children and adolescents from 6 to less than 18 years of age:
The recommended initial dose is 10 mg per day. If the patient's blood pressure is not adequately controlled, the doctor may decide to change the dose to 20 or 40 mg once daily. In children who weigh less than 35 kg, the dose will not exceed 20 mg once daily.
If you take more Ixia than you should
If you take more tablets than you should or if a child has taken some by accident, contact your doctor or the nearest hospital emergency department immediately and take the medicine pack with you.
In case of overdose or accidental ingestion, consult the Toxicological Information Service. Telephone 91 562 04 20.
If you forget to take Ixia
If you forget to take a dose, take the usual dose the next day. Do not take a double dose to make up for forgotten doses.
If you stop taking Ixia
It is important to continue taking Ixia unless your doctor tells you to stop.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them. If they do occur, they are usually mild and do not require treatment to be stopped.
The following side effects may be serious, although they are rare.
In rare cases (affecting up to 1 in 1,000 people), the following allergic reactions have been reported, which can affect the whole body: swelling of the face, mouth, and/or larynx, along with itching and skin rash. If this happens to you, stop taking Ixia and consult your doctor immediately.
Rarely (but slightly more often in elderly patients), Ixia may cause a pronounced drop in blood pressure, in susceptible patients or as a result of an allergic reaction. This can cause fainting or severe dizziness. If this happens to you, stop taking Ixia, consult your doctor immediately, and remain lying down.
Frequency not known: If you experience yellowing of the whites of the eyes, dark urine, itching of the skin, even if you started treatment with Ixia a long time ago, contact your doctor immediatelywho will assess your symptoms and decide how to proceed with your blood pressure treatment.
These are other known side effects of Ixia:
Common side effects (affecting up to 1 in 10 people):
Dizziness, headache, nausea, indigestion, diarrhea, stomach pain, gastroenteritis, fatigue, sore throat, nasal congestion and discharge, bronchitis, flu-like symptoms, cough, pain, chest pain, back pain, bone pain, joint pain, urinary tract infection, swelling of ankles, feet, legs, hands, arms, blood in urine.
Some changes in the results of certain blood tests have also been observed:
increase in fat levels (hypertriglyceridemia), increase in uric acid levels (hyperuricemia), increase in urea in the blood, increases in liver and muscle function test values.
Uncommon side effects (affecting up to 1 in 100 people):
Rapid allergic reactions that can affect the whole body and cause breathing problems, as well as a rapid drop in blood pressure that can lead to fainting (anaphylactic reactions), swelling of the face, dizziness, vomiting, weakness, feeling unwell, muscle pain, skin rash, allergic skin rash, itching, skin eruption (skin rash), hives (skin swelling), angina (chest pain or discomfort).
In blood tests, a decrease in the number of a type of blood cell called platelets (thrombocytopenia) has been observed.
Rare side effects (affecting up to 1 in 1,000 people):
Lack of energy, muscle cramps, worsening of kidney function, kidney failure; intestinal angioedema: swelling in the intestine that occurs with symptoms such as abdominal pain, nausea, vomiting, and diarrhea.
Some changes in the results of certain blood tests have been observed, including an increase in potassium levels in the blood (hyperkalemia) and an increase in components related to kidney function.
Other side effects in children and adolescents:
In children, side effects similar to those reported in adults have been observed. However, dizziness and headache have been observed more frequently in children, and nosebleeds are a common side effect observed only in children.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Medicines and Healthcare Products Agency's (AEMPS) website: www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister (after “EXP.”). The expiry date refers to the last day of the month shown.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
What Ixia contains
The active substance is olmesartan medoxomil.
Each film-coated tablet contains 10 mg of olmesartan medoxomil.
The other ingredients are microcrystalline cellulose, lactose monohydrate, hydroxypropylcellulose, low-substituted hydroxypropylcellulose, magnesium stearate, titanium dioxide (E171), talc, and hypromellose (see section 2 “Ixia contains lactose”).
Appearance and packaging
Ixia 10 mg film-coated tablets are white, round, with the inscription C13 on one side.
Ixia film-coated tablets are available in packs of 14, 28, 30, 56, 84, 90, 98, and 10 x 28 tablets, and in packs with pre-cut unit-dose blisters of 10, 50, and 500 tablets.
Not all packs are marketed.
Marketing authorisation holder
Menarini International Operations Luxembourg, S.A.
1, Avenue de la Gare L-1611 Luxembourg
Manufacturer
Berlin-Chemie AG
Glienicker Weg 125, D-12489 Berlin
Germany
Or
DAIICHI SANKYO EUROPE GmbH
Luitpoldstrasse 1
85276 Pfaffenhofen
Germany
or
Laboratorios Menarini, S.A.
Alfons XII, 587 – E 08918 Badalona (Barcelona)
or
Qualiphar N.V.
Rijksweg 9, 2880 Bornem
Belgium
or
Menarini - Von Heyden GmbH (MvH)
Leipziger Strasse 7-13
01097 Dresden,
Germany
For further information about this medicine, please contact the local representative of the marketing authorisation holder
Laboratorios Menarini, S.A.
Alfons XII, 587 - Badalona (Barcelona) Spain
“under licence from Daiichi Sankyo Europe GmbH”
This medicine is authorised in the Member States of the European Economic Area under the following names:
Austria: Mencord
Belgium: Belsar
Cyprus: Olartan
Czech Republic: Sarten
Denmark: Benetor
Germany: Votum
Greece: Olartan
Finland: Benetor
France: Alteis
Iceland: Benetor
Ireland: Omesar
Italy: Olpress
Luxembourg: Belsar
Malta: Omesar
Norway: Benetor
Poland: Revival
Portugal: Olsar
Slovenia: Tensiol
Spain: Ixia
Date of last revision of this leaflet:01/2025
Other sources of information
Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es/
The average price of IXIA 10 mg FILM-COATED TABLETS in October, 2025 is around 5.04 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.